Global NewsNews

Oncoshot forms SEA genomic data digitisation collaboration to improve cancer clinical trial access

Partners with Icon Cancer Centre in Singapore, alongside Roche

Oncoshot has announced one of its biggest collaborations to date with Icon Cancer Centre in Singapore, alongside Roche. Together the partners plan to facilitate more comprehensive genomic profiling data to increase access to more trial options for cancer patients. This first-ever collaboration in SEA will help advance the biopharmaceutical research and development ecosystem for healthcare professionals, institutions and patients by taking a more personalised approach to care and offering people with cancer more treatment options.

Through this collaboration, Oncoshot, Icon and Roche will be able to easily identify cancer patients who are a match for existing clinical trials being run within their networks. Furthermore, real-time population matching will also enable companies and clinical research organisations (CROs) on the Oncoshot clinical trial platform to engage Icon as a preferred clinical trial centre, increasing patient access to clinical trial options for their cancer.

“This collaboration marks our commitment to advancing cancer care and increasing access to the latest in cancer clinical trials. By digitising a patient’s genomic profile, we can accelerate the process of matching patients to the most suitable clinical trials,” said Serena Wee, CEO, Icon ASEAN and Hong Kong. “By investing in this partnership, our patients can access new and emerging advances in cancer treatment quicker, giving them and their families new hope and opportunities.”

“With comprehensive genomic profiling (CGP) data, healthcare professionals can make more informed decisions for their patients about potential treatment options, which should include access to clinical trials of investigational new medicines,” said Ying Ying Yeoh, General Manager for Roche Singapore. “We are proud to partner with Oncoshot and Icon to help more patients in our collective fight against cancer, and advance clinical cancer research in APAC to bring more medicines to patients sooner.” 


Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.


Related Articles

Back to top button